Posted inUncategorized
Replacing the R&D Director with AI: How REGEMAT 3D Can Increase EBITDA by $1M in 12 Months
REGEMAT 3D, a global player in the 3D bioprinting and regenerative medicine market, is considering introducing a new Director-level management role to coordinate R&D projects and manage grant activities. An…